about
Peroxisome proliferator-activated receptors family is involved in the response to treatment and mild clinical course in patients with ulcerative colitis.Caenorhabditis elegans susceptibility to gut Enterococcus faecalis infection is associated with fat metabolism and epithelial junction integrity.Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatmentIdentification of Haplotype Tag Single-Nucleotide Polymorphisms within the PPAR Family Genes and Their Clinical Relevance in Patients with Major TraumaRegulation of the mucosal phenotype in dendritic cells by PPARγ: role of tissue microenvironment.Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.Differentially expressed genes in PPARγ-deficient MSCs.Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells.Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?Roles of Probiotic Lactobacilli Inclusion in Helping Piglets Establish Healthy Intestinal Inter-environment for Pathogen Defense.The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces.Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells.Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritisClinical relevance of peroxisome proliferator-activated receptor-γ gene polymorphisms with sepsis.Involvement of PPARγ in the protective action of tropisetron in an experimental model of ulcerative colitis.Idebenone and coenzyme Q10are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases
P2860
Q34762999-CCA1CB7D-420C-4E7D-A299-D7FDF12C9F72Q35894654-02B9458B-1D56-41A4-AB83-F8E7099E0B3AQ36269059-E983255C-3EB7-49F5-A89E-DE47D71DEDB3Q36841634-1A283707-6074-4F73-B3A4-0209491A5365Q37581433-91BB809A-2DD7-46DB-AB71-E1F993598666Q38561218-AF549FA4-C73A-42FF-ACC4-2E944B6A51CCQ38642592-AC15F762-3DEF-460F-A183-DC84CAE3DE17Q38713387-92773F88-DF14-4D14-9065-F54D142AE79EQ38828232-C71D4DF6-B5F6-41E7-AED0-99398BDB17D5Q39210407-CA721F44-0532-4B27-9A80-0C2A3DED33EEQ41159836-F6EBACB6-18A0-41B4-B024-C5E22F26AD9EQ41688465-C1CDD1A8-441A-4F4A-ABB7-B39CA1649571Q41888146-94324F11-17FE-4BB5-B1DA-27D8A7B5A541Q48152839-C193A28B-5600-40A6-AB38-EB1D6ACC2CEDQ48505520-80021E4B-45F6-4317-A1F6-DC2FF6B0A494Q57269164-A3E39129-A31A-41F8-8160-3DF778D04EA1
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PPARγ in Inflammatory Bowel Disease.
@en
PPARγ in Inflammatory Bowel Disease.
@nl
type
label
PPARγ in Inflammatory Bowel Disease.
@en
PPARγ in Inflammatory Bowel Disease.
@nl
prefLabel
PPARγ in Inflammatory Bowel Disease.
@en
PPARγ in Inflammatory Bowel Disease.
@nl
P2093
P2860
P356
P1433
P1476
PPARγ in Inflammatory Bowel Disease.
@en
P2093
Alessia Settesoldi
Francesca Rogai
Siro Bagnoli
Vito Annese
P2860
P304
P356
10.1155/2012/620839
P577
2012-09-10T00:00:00Z